Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Arthritis, Rheumatoid, Date of authorisation: 13/02/2017, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Arthritis, Rheumatoid, Date of authorisation: 13/02/2017, Revision: 17, Status: Authorised
